https://news.medxy.ai/zh/interleukin-6-in-acute-lung-injury-covid19/Medxy AIzh2026-08-06T12:56:07-07:00白细胞介素-6：急性肺损伤与COVID-19治疗获益的关键枢纽 https://news.medxy.ai/ja/interleukin-6-in-acute-lung-injury-covid-19/Medxy AIja2026-08-06T12:55:50-07:00急性肺障害とCOVID-19における治療成功を導く中心因子としてのInterleukin-6 https://news.medxy.ai/vi/interleukin-6-in-acute-lung-injury-and-covid-19/Medxy AIvi2026-08-06T12:55:24-07:00IL-6: mắt xích trung tâm quyết định hiệu quả điều trị trong tổn thương phổi cấp và COVID-19 https://news.medxy.ai/interleukin-6-as-a-central-mediator-of-therapeutic-success-in-acute-lung-injury-and-covid-19/Medxy AIen2026-08-06T12:54:35-07:00Interleukin-6 as a Central Mediator of Therapeutic Success in Acute Lung Injury and COVID-19 https://news.medxy.ai/zh/understanding-and-reducing-diagnostic-delays-in-childhood-uveitis/Medxy AIzh2026-08-06T12:00:29-07:00缩短儿童起病葡萄膜炎的诊断延误：识别并减少确诊迟滞 https://news.medxy.ai/ja/reducing-diagnostic-delays-in-childhood-onset-uveitis/Medxy AIja2026-08-06T12:00:12-07:00小児発症ブドウ膜炎の診断遅延をどう減らすか：その要因と対策を読み解く https://news.medxy.ai/vi/understanding-and-reducing-diagnostic-delays-in-childhood-onset-uveitis/Medxy AIvi2026-08-06T11:59:51-07:00Vượt qua khoảng trễ chẩn đoán: hiểu và giảm trì hoãn trong uveitis khởi phát ở trẻ em https://news.medxy.ai/bridging-the-gap-understanding-and-reducing-diagnostic-delays-in-childhood-onset-uveitis/Medxy AIen2026-08-06T11:59:02-07:00Bridging the Gap: Understanding and Reducing Diagnostic Delays in Childhood Onset Uveitis https://news.medxy.ai/zh/global-axial-length-centile-for-myopia-management-in-children-and-adolescents/Medxy AIzh2026-08-06T11:58:23-07:00全球儿童青少年眼轴长度百分位曲线：近视管理的新参考标准 https://news.medxy.ai/ja/global-axial-length-centile-charts-for-myopia-management-in-children-and-adolescents/Medxy AIja2026-08-06T11:58:08-07:00小児・思春期の近視管理に役立つ新指標：世界規模の眼軸長パーセンタイルチャート https://news.medxy.ai/vi/myopia-management-in-children-and-adolescents/Medxy AIvi2026-08-06T11:57:49-07:00Biểu đồ bách phân vị độ dài trục nhãn cầu toàn cầu: Nguồn tham chiếu mới cho quản lý cận thị ở trẻ em và thanh thiếu niên https://news.medxy.ai/global-axial-length-centile-charts-a-new-reference-for-myopia-management-in-children-and-adolescents/Medxy AIen2026-08-06T11:56:59-07:00Global Axial Length Centile Charts: A New Reference for Myopia Management in Children and Adolescents https://news.medxy.ai/zh/interleukin-6-inhibition-reduce-diabetic-retinopathy-risk/Medxy AIzh2026-08-06T11:48:04-07:00系统性白细胞介素-6抑制：降低糖尿病视网膜病变风险与进展的新策略 https://news.medxy.ai/ja/systemic-interleukin-6-inhibition-reduce-diabetic-retinopathy-risk/Medxy AIja2026-08-06T11:47:46-07:00全身性IL-6阻害は糖尿病網膜症のリスクと進行を抑える新たな治療戦略 https://news.medxy.ai/vi/systemic-interleukin-6-inhibition-reduce-diabetic-retinopathy-risk-and-progression/Medxy AIvi2026-08-06T11:47:27-07:00Ức chế interleukin-6 toàn thân: hướng đi mới đầy hứa hẹn trong giảm nguy cơ và tiến triển bệnh võng mạc đái tháo đường https://news.medxy.ai/systemic-interleukin-6-inhibition-as-a-novel-approach-to-reduce-diabetic-retinopathy-risk-and-progression/Medxy AIen2026-08-06T11:46:40-07:00Systemic Interleukin-6 Inhibition as a Novel Approach to Reduce Diabetic Retinopathy Risk and Progression https://news.medxy.ai/zh/patient-characteristics-on-treatment-choices-in-bilateral-vocal-fold-atrophy/Medxy AIzh2026-08-06T11:23:43-07:00双侧声带萎缩治疗如何选择？一项十年临床数据揭示患者关键特征 https://news.medxy.ai/vi/patient-characteristics-influencing-treatment-choices-in-bilateral-vocal-fold-atrophy/Medxy AIvi2026-08-06T11:23:06-07:00Những yếu tố ở người bệnh chi phối lựa chọn điều trị trong teo hai bên dây thanh: Góc nhìn từ dữ liệu lâm sàng 10 năm https://news.medxy.ai/patient-characteristics-influencing-treatment-choices-in-bilateral-vocal-fold-atrophy-insights-from-a-decade-of-clinical-data/Medxy AIen2026-08-06T11:21:15-07:00Patient Characteristics Influencing Treatment Choices in Bilateral Vocal Fold Atrophy: Insights from a Decade of Clinical Data https://news.medxy.ai/zh/sex-disparities-in-surgical-robot-assisted-surgery/Medxy AIzh2026-08-06T11:12:10-07:00机器人辅助外科早期推广中的手术机会性别差异 https://news.medxy.ai/ja/sex-based-disparities-in-surgical-robot-assisted-surgery/Medxy AIja2026-08-06T11:10:54-07:00ロボット支援手術の導入初期における手術機会の性差 https://news.medxy.ai/vi/sex-based-disparities-in-surgical-opportunities-robot-assisted-surgery/Medxy AIvi2026-08-06T11:09:00-07:00Chênh lệch theo giới trong cơ hội phẫu thuật ở giai đoạn đầu áp dụng phẫu thuật hỗ trợ robot https://news.medxy.ai/sex-based-disparities-in-surgical-opportunities-during-early-adoption-of-robot-assisted-surgery/Medxy AIen2026-08-06T11:07:21-07:00Sex-Based Disparities in Surgical Opportunities During Early Adoption of Robot-Assisted Surgery https://news.medxy.ai/zh/resection-margin-status-in-distal-cholangiocarcinoma-link-recurrence-and-adjuvant-radiotherapy-selection/Medxy AIzh2026-08-06T11:06:43-07:00远端胆管癌切缘状态的预后价值：复发风险与辅助放疗选择 https://news.medxy.ai/ja/resection-margin-status-in-distal-cholangiocarcinoma/Medxy AIja2026-08-06T11:06:06-07:00遠位胆管癌における切除断端状態の意味：再発リスクと術後放射線療法選択への示唆 https://news.medxy.ai/vi/resection-margin-status-in-distal-cholangiocarcinoma-recurrence-and-adjuvant-radiotherapy-selection/Medxy AIvi2026-08-06T11:05:47-07:00Tình trạng bờ cắt sau phẫu thuật ở ung thư đường mật đoạn xa: Ý nghĩa đối với nguy cơ tái phát và lựa chọn xạ trị bổ trợ https://news.medxy.ai/resection-margin-status-in-distal-cholangiocarcinoma-implications-for-recurrence-and-adjuvant-radiotherapy-selection/Medxy AIen2026-08-06T11:04:35-07:00Resection Margin Status in Distal Cholangiocarcinoma: Implications for Recurrence and Adjuvant Radiotherapy Selection https://news.medxy.ai/zh/preoperative-weight-loss-in-obese-women-with-hyperplasia-or-endometrial-cancer/Medxy AIzh2026-08-06T10:35:44-07:00肥胖女性合并非典型增生或低级别子宫内膜癌的术前减重：可行性与结局 https://news.medxy.ai/ja/preoperative-weight-loss-in-obese-women-with-atypical-hyperplasia-or-endometrial-cancer/Medxy AIja2026-08-06T10:35:25-07:00肥満女性の異型過形成・低悪性度子宮内膜癌に対する術前減量：実施可能性と転帰 https://news.medxy.ai/vi/preoperative-weight-loss-in-obese-women-with-atypical-hyperplasia-or-low-grade-endometrial-cancer/Medxy AIvi2026-08-06T10:34:59-07:00Giảm cân trước phẫu thuật ở phụ nữ béo phì mắc tăng sản không điển hình hoặc ung thư nội mạc tử cung độ thấp: Tính khả thi và kết cục https://news.medxy.ai/preoperative-weight-loss-in-obese-women-with-atypical-hyperplasia-or-low-grade-endometrial-cancer-feasibility-and-outcomes/Medxy AIen2026-08-06T10:33:14-07:00Preoperative Weight Loss in Obese Women With Atypical Hyperplasia or Low-Grade Endometrial Cancer: Feasibility and Outcomes https://news.medxy.ai/zh/ultrasound-guided-enucleation-in-robotic-myomectomy/Medxy AIzh2026-08-06T10:29:38-07:00机器人肌瘤剔除术更精准：借助可放入式超声探头实现超声引导下剥除 https://news.medxy.ai/ja/ultrasound-guided-enucleation-using-a-drop-probe-in-robotic-myomectomy/Medxy AIja2026-08-06T10:29:13-07:00ロボット支援下子宮筋腫核出術の精度向上：ドロップイン型プローブを用いた超音波ガイド下核出術 https://news.medxy.ai/vi/ultrasound-guided-enucleation-using-a-drop-in-probe-in-robotic-myomectomy/Medxy AIvi2026-08-06T10:28:56-07:00Nâng cao độ chính xác trong bóc nhân xơ tử cung hỗ trợ bằng robot: bóc tách dưới hướng dẫn siêu âm với đầu dò drop-in https://news.medxy.ai/enhancing-precision-in-robotic-myomectomy-ultrasound-guided-enucleation-using-a-drop-in-probe/Medxy AIen2026-08-06T10:28:08-07:00Enhancing Precision in Robotic Myomectomy: Ultrasound-Guided Enucleation Using a Drop-In Probe https://news.medxy.ai/zh/nonopioid-and-opioid-pain-management-after-laparoscopic-hysterectomy-from-rct/Medxy AIzh2026-08-06T10:27:41-07:00腹腔镜子宫切除术后镇痛：非阿片方案能否替代阿片处方？一项非劣效性随机试验 https://news.medxy.ai/ja/nonopioid-and-opioid-pain-management-after-laparoscopic-hysterectomy-rct/Medxy AIja2026-08-06T10:27:23-07:00腹腔鏡下子宮全摘術後の鎮痛：非オピオイドはオピオイドに劣らないか https://news.medxy.ai/vi/nonopioid-vs-opioid-pain-management-after-laparoscopic-hysterectomy/Medxy AIvi2026-08-06T10:27:06-07:00Giảm đau không opioid hay opioid sau cắt tử cung nội soi: kết quả từ một thử nghiệm ngẫu nhiên không kém hơn https://news.medxy.ai/nonopioid-vs-opioid-pain-management-after-laparoscopic-hysterectomy-a-noninferiority-randomized-trial/Medxy AIen2026-08-06T10:26:12-07:00Nonopioid vs Opioid Pain Management After Laparoscopic Hysterectomy: A Noninferiority Randomized Trial https://news.medxy.ai/zh/pegylated-interferon-after-nucleostide-withdrawal-boosts-hbsag-loss/Medxy AIzh2026-08-06T10:25:15-07:00乙型肝炎治疗新进展：核苷（酸）类似物停药后加用聚乙二醇化干扰素，可提高HBeAg阴性患者HBsAg清除率 https://news.medxy.ai/ja/peg-interferon-after-nucleostide-withdrawal-boosts-hbsag-loss-in-hbeag-negative-patients/Medxy AIja2026-08-06T10:24:58-07:00B型肝炎治療の新展開：ヌクレオシ(t)ド中止後のペグ化インターフェロン併用でHBeAg陰性例のHBs抗原消失が向上 https://news.medxy.ai/vi/pegylated-interferon-after-nucleostide-withdrawal-boosts-hbsag-loss-in-hbeag-negative-patients/Medxy AIvi2026-08-06T10:24:37-07:00Tăng hiệu quả điều trị viêm gan B: pegylated interferon sau ngừng nucleos(t)ide analogue giúp cải thiện mất HBsAg ở bệnh nhân HBeAg âm tính https://news.medxy.ai/enhancing-hepatitis-b-treatment-pegylated-interferon-after-nucleostide-withdrawal-boosts-hbsag-loss-in-hbeag-negative-patients/Medxy AIen2026-08-06T10:23:43-07:00Enhancing Hepatitis B Treatment: Pegylated Interferon After Nucleos(t)ide Withdrawal Boosts HBsAg Loss in HBeAg-Negative Patients https://news.medxy.ai/zh/subtype-specific-enteric-neuronal-activation-in-ibs-linking-faecal-proteases/Medxy AIzh2026-08-06T10:22:42-07:00IBS亚型特异性肠神经元激活：粪便蛋白酶与免疫特征的联系 https://news.medxy.ai/ja/subtype-specific-enteric-neuronal-activation-in-ibs-linking-faecal-proteases-and-immune/Medxy AIja2026-08-06T10:22:24-07:00IBSサブタイプ別の腸管神経活性化：糞便中プロテアーゼと免疫シグネチャーの関連 https://news.medxy.ai/vi/subtype-specific-enteric-neuronal-activation-in-ibs/Medxy AIvi2026-08-06T10:22:05-07:00IBS: Kích hoạt nơron ruột đặc hiệu theo thể bệnh liên quan đến protease và dấu ấn miễn dịch trong phân https://news.medxy.ai/subtype-specific-enteric-neuronal-activation-in-ibs-linking-faecal-proteases-and-immune-signatures/Medxy AIen2026-08-06T10:20:51-07:00Subtype-Specific Enteric Neuronal Activation in IBS: Linking Faecal Proteases and Immune Signatures https://news.medxy.ai/zh/liver-stiffness-measurements-for-primary-sclerosing-cholangitis/Medxy AIzh2026-08-06T10:19:42-07:00Fibroscan®肝脏硬度测量在原发性硬化性胆管炎中的预后价值：来自前瞻性FICUS队列的研究洞见 https://news.medxy.ai/ja/liver-stiffness-measurements-in-primary-sclerosing-cholangitis/Medxy AIja2026-08-06T10:19:27-07:00原発性硬化性胆管炎の予後予測における肝硬度測定の有用性：前向きFICUSコホートからの知見 https://news.medxy.ai/vi/liver-stiffness-measurements-as-prognostic-tools-in-primary-sclerosing-cholangitis/Medxy AIvi2026-08-06T10:19:10-07:00Độ cứng gan như một công cụ tiên lượng trong viêm đường mật xơ hóa tiên phát: phát hiện từ đoàn hệ FICUS tiến cứu https://news.medxy.ai/liver-stiffness-measurements-as-prognostic-tools-in-primary-sclerosing-cholangitis-insights-from-the-prospective-ficus-cohort/Medxy AIen2026-08-06T10:17:42-07:00Liver Stiffness Measurements as Prognostic Tools in Primary Sclerosing Cholangitis: Insights from the Prospective FICUS Cohort https://news.medxy.ai/zh/persistence-of-blood-inflammatory-biomarkers-for-long-term-recurrent-stroke-risk-from-the-oxford-vascular-study/Medxy AIzh2026-08-06T09:51:42-07:00血液炎症标志物持续预测长期卒中复发风险：来自牛津血管研究的启示 https://news.medxy.ai/ja/persistence-of-blood-inflammatory-biomarkers-for-long-term-recurrent-stroke-risk/Medxy AIja2026-08-06T09:51:24-07:00血液炎症バイオマーカーは長期脳卒中再発を予測するのか――Oxford Vascular Studyから見えたこと https://news.medxy.ai/vi/persistence-of-blood-inflammatory-biomarkers-for-long-term-recurrent-stroke-risk-insights-from-the-oxford-vascular-study/Medxy AIvi2026-08-06T09:51:02-07:00Dấu ấn viêm trong máu kéo dài: yếu tố dự báo nguy cơ đột quỵ tái phát lâu dài từ nghiên cứu Oxford Vascular Study https://news.medxy.ai/persistence-of-blood-inflammatory-biomarkers-as-predictors-of-long-term-recurrent-stroke-risk-insights-from-the-oxford-vascular-study/Medxy AIen2026-08-06T09:49:16-07:00Persistence of Blood Inflammatory Biomarkers as Predictors of Long-Term Recurrent Stroke Risk: Insights From the Oxford Vascular Study https://news.medxy.ai/zh/ferritin-and-inflammation-in-isolated-rem-sleep-behavior-disorder/Medxy AIzh2026-08-06T09:48:10-07:00孤立性REM睡眠行为障碍中血清铁蛋白与炎症：纵向队列研究新见 https://news.medxy.ai/ja/serum-ferritin-and-inflammation-in-rem-sleep-behavior-disorder/Medxy AIja2026-08-06T09:47:49-07:00孤発性REM睡眠行動障害における血清フェリチンと炎症：縦断コホート研究からみた新知見 https://news.medxy.ai/vi/serum-ferritin-and-inflammation-in-isolated-rem-sleep-behavior-disorder/Medxy AIvi2026-08-06T09:47:20-07:00Ferritin huyết thanh và viêm trong rối loạn hành vi giấc ngủ REM đơn độc: bằng chứng từ các nghiên cứu đoàn hệ theo dõi dọc https://news.medxy.ai/serum-ferritin-and-inflammation-in-isolated-rem-sleep-behavior-disorder-insights-from-longitudinal-cohort-studies/Medxy AIen2026-08-06T09:45:06-07:00Serum Ferritin and Inflammation in Isolated REM Sleep Behavior Disorder: Insights from Longitudinal Cohort Studies https://news.medxy.ai/zh/automated-speech-in-primary-progressive-aphasia/Medxy AIzh2026-08-06T08:41:12-07:00原发性进行性失语症中的自动语音分析：诊断、解剖与病理新见解 https://news.medxy.ai/ja/automated-speech-analysis-in-primary-progressive-aphasia/Medxy AIja2026-08-06T08:40:53-07:00原発性進行性失語症における自動発話解析：診断・解剖・病理からみた知見 https://news.medxy.ai/vi/automated-speech-analysis-in-primary-progressive-aphasia-diagnostic-anatomical/Medxy AIvi2026-08-06T08:40:31-07:00Phân tích lời nói tự động trong chứng mất ngôn ngữ tiến triển nguyên phát: Những hiểu biết chẩn đoán, giải phẫu và bệnh lý học thần kinh https://news.medxy.ai/automated-speech-analysis-in-primary-progressive-aphasia-diagnostic-anatomical-and-pathological-insights/Medxy AIen2026-08-06T08:37:59-07:00Automated Speech Analysis in Primary Progressive Aphasia: Diagnostic, Anatomical, and Pathological Insights https://news.medxy.ai/zh/survival-and-predictors-in-genetic-frontotemporal-dementia-2/Medxy AIzh2026-08-05T14:15:53-07:00遗传性额颞叶痴呆的生存期与预测因素：一项国际回顾性队列研究的启示 https://news.medxy.ai/ja/survival-and-predictors-in-genetic-frontotemporal-dementia/Medxy AIja2026-08-05T14:15:30-07:00遺伝性前頭側頭型認知症の生存期間と予後因子：国際後ろ向きコホート研究からの知見 https://news.medxy.ai/vi/survival-estimates-and-predictors-in-genetic-frontotemporal-dementia/Medxy AIvi2026-08-05T14:15:06-07:00Ước tính sống còn và các yếu tố dự báo trong sa sút trí tuệ thùy trán-thái dương di truyền: Bằng chứng từ một nghiên cứu đoàn hệ hồi cứu quốc tế https://news.medxy.ai/survival-estimates-and-predictors-in-genetic-frontotemporal-dementia-insights-from-an-international-retrospective-cohort-study/Medxy AIen2026-08-05T14:13:50-07:00Survival Estimates and Predictors in Genetic Frontotemporal Dementia: Insights from an International Retrospective Cohort Study https://news.medxy.ai/zh/maternal-third-trimester-trab-levels-on-neonatal-thyroid-function-and-early-childhood-neurodevelopment/Medxy AIzh2026-08-05T14:07:26-07:00母体妊娠晚期TRAb水平对新生儿甲状腺功能及儿童早期神经发育的影响：来自双向队列研究的启示 https://news.medxy.ai/ja/maternal-third-trimester-trab-levels-on-neonatal-thyroid-function-and-early-childhood-neurodevelopment-insights-from-a-bidirectional-cohort-study/Medxy AIja2026-08-05T14:07:06-07:00妊娠後期の母体TRAb高値は新生児甲状腺機能と乳幼児の神経発達にどう影響するか：双方向コホート研究からの示唆 https://news.medxy.ai/vi/impact-of-maternal-third-trimester-trab-levels-on-neonatal-thyroid-function-and-early-childhood-neurodevelopment-from-a-bidirectional-cohort-study/Medxy AIvi2026-08-05T14:06:43-07:00TRAb của mẹ ở tam cá nguyệt thứ ba ảnh hưởng thế nào đến chức năng tuyến giáp sơ sinh và phát triển thần kinh sớm của trẻ? https://news.medxy.ai/impact-of-maternal-third-trimester-trab-levels-on-neonatal-thyroid-function-and-early-childhood-neurodevelopment-insights-from-a-bidirectional-cohort-study/Medxy AIen2026-08-05T14:05:53-07:00Impact of Maternal Third-Trimester TRAb Levels on Neonatal Thyroid Function and Early Childhood Neurodevelopment: Insights from a Bidirectional Cohort Study https://news.medxy.ai/zh/polygenic-scores-to-predict-diabetes-risk-after-gestational-diabetes-from-a-30-year-cohort-study/Medxy AIzh2026-08-05T13:54:00-07:00借助多基因评分预测妊娠期糖尿病后的糖尿病风险：一项30年队列研究的启示 https://news.medxy.ai/ja/leveraging-polygenic-scores-to-predict-diabetes-risk-after-gestational-diabetes-from-a-30-year-cohort-study/Medxy AIja2026-08-05T13:53:40-07:00妊娠糖尿病後の糖尿病リスク予測におけるpolygenic scoreの活用：30年追跡コホート研究からの知見 https://news.medxy.ai/leveraging-polygenic-scores-to-predict-diabetes-risk-after-gestational-diabetes-insights-from-a-30-year-cohort-study/Medxy AIen2026-08-05T13:52:33-07:00Leveraging Polygenic Scores to Predict Diabetes Risk After Gestational Diabetes: Insights from a 30-Year Cohort Study https://news.medxy.ai/zh/partial-lipodystrophy-cushings-syndrome/Medxy AIzh2026-08-05T13:51:22-07:00部分性脂肪营养不良与库欣综合征如何区分：临床重叠与诊断难点 https://news.medxy.ai/ja/partial-lipodystrophy-from-cushings-syndrome/Medxy AIja2026-08-05T13:51:04-07:00部分性脂肪萎縮症とCushing症候群を見分けるには：臨床像の重なりと診断の難しさ https://news.medxy.ai/vi/distinguishing-partial-lipodystrophy-from-cushings-syndrome/Medxy AIvi2026-08-05T13:50:42-07:00Phân biệt loạn dưỡng mỡ một phần với hội chứng Cushing: những điểm giao thoa lâm sàng và thách thức chẩn đoán https://news.medxy.ai/distinguishing-partial-lipodystrophy-from-cushings-syndrome-clinical-overlaps-and-diagnostic-challenges/Medxy AIen2026-08-05T13:49:39-07:00Distinguishing Partial Lipodystrophy from Cushing’s Syndrome: Clinical Overlaps and Diagnostic Challenges https://news.medxy.ai/zh/prior-authorization-suspension-boosts-to-diabetes-and-improves-glycemic-control-in-populations/Medxy AIzh2026-08-05T13:49:29-07:00暂停事先授权，有助于扩大糖尿病技术可及性并改善弱势人群血糖控制 https://news.medxy.ai/ja/prior-authorization-suspension-boosts-to-diabetes-technology-and-improves-glycemic-control-in-populations/Medxy AIja2026-08-05T13:49:11-07:00事前承認停止で糖尿病テクノロジーへのアクセスが拡大し、医療資源の乏しい集団の血糖管理が改善 https://news.medxy.ai/vi/prior-authorization-suspension-boosts-access-to-diabetes-technology-and-improves-glycemic-control-in-populations/Medxy AIvi2026-08-05T13:48:50-07:00Tạm ngừng phê duyệt trước giúp mở rộng tiếp cận công nghệ đái tháo đường và cải thiện kiểm soát đường huyết ở nhóm dân cư thiếu thụ hưởng https://news.medxy.ai/prior-authorization-suspension-boosts-access-to-diabetes-technology-and-improves-glycemic-control-in-underserved-populations/Medxy AIen2026-08-05T13:48:02-07:00Prior Authorization Suspension Boosts Access to Diabetes Technology and Improves Glycemic Control in Underserved Populations https://news.medxy.ai/zh/donor-heart-preservation-outcomes-with-10c-versus-4-8c-in-adult-heart-transplantation/Medxy AIzh2026-08-05T13:46:42-07:00优化供心保存：成人心脏移植中10°C较4–8°C可获得更优结局 https://news.medxy.ai/ja/donor-heart-preservation-superior-outcomes-with-10c-versus-4-8c-in-adult-heart-transplantation/Medxy AIja2026-08-05T13:46:25-07:00ドナー心保存の最適化：成人心臓移植では4～8°Cより10°Cが優れることを示した研究 https://news.medxy.ai/optimizing-donor-heart-preservation-superior-outcomes-with-10c-versus-4-8c-in-adult-heart-transplantation/Medxy AIen2026-08-05T13:45:18-07:00Optimizing Donor Heart Preservation: Superior Outcomes with 10°C Versus 4-8°C in Adult Heart Transplantation https://news.medxy.ai/ja/womens-heart-centres-esc-consensus-on-sex-sensitive-cardiovascular-care/Medxy AIja2026-08-05T13:06:36-07:00女性の心臓センターをどうつくるか：ESCが示した、性差に配慮した心血管ケアの新たなコンセンサス https://news.medxy.ai/zh/womens-heart-centres-the-esc-consensus-on-sex-sensitive-cardiovascular-care/Medxy AIzh2026-08-05T13:05:25-07:00女性心脏中心：ESC关于组织化、性别敏感心血管照护的共识 https://news.medxy.ai/womens-heart-centres-the-esc-consensus-on-organized-sex-sensitive-cardiovascular-care/Medxy AIen2026-08-05T13:02:08-07:00Women’s Heart Centres: The ESC Consensus on Organized, Sex-Sensitive Cardiovascular Care https://news.medxy.ai/zh/elective-left-ventricular-unloading-in-high-risk-pci-bcis3-substudy/Medxy AIzh2026-08-05T12:51:46-07:00高危PCI中择期左心室卸载的价值：来自CHIP-BCIS3亚组研究的启示 https://news.medxy.ai/ja/elective-left-ventricular-unloading-in-high-risk-pci-chip-bcis3-substudy/Medxy AIja2026-08-05T12:51:31-07:00高リスクPCIにおける待機的左室アンローディングの評価：CHIP-BCIS3サブスタディからの知見 https://news.medxy.ai/vi/evaluating-elective-left-ventricular-unloading-in-high-risk-pci-chip-bcis3-substudy/Medxy AIvi2026-08-05T12:51:12-07:00Đánh giá giảm tải thất trái có chủ đích trong PCI nguy cơ cao: Kết quả từ phân tích phụ CHIP-BCIS3 https://news.medxy.ai/evaluating-elective-left-ventricular-unloading-in-high-risk-pci-insights-from-the-chip-bcis3-substudy/Medxy AIen2026-08-05T12:50:26-07:00Evaluating Elective Left Ventricular Unloading in High-Risk PCI: Insights from the CHIP-BCIS3 Substudy https://news.medxy.ai/zh/extracranial-bleeding-on-oral-anticoagulants-in-af/Medxy AIzh2026-08-05T12:08:08-07:00心房颤动口服抗凝治疗中的心外出血风险：COMBINE-AF分析新启示 https://news.medxy.ai/ja/extracranial-bleeding-risk-on-oral-anticoagulants-in-af/Medxy AIja2026-08-05T12:07:48-07:00心房細動における経口抗凝固薬の頭蓋内以外出血リスク：COMBINE-AF解析から見えたもの https://news.medxy.ai/vi/extracranial-bleeding-risk-on-oral-anticoagulants-in-atrial-fibrillation/Medxy AIvi2026-08-05T12:07:23-07:00Nguy cơ xuất huyết ngoài sọ khi dùng thuốc chống đông đường uống ở rung nhĩ: phân tích từ COMBINE-AF https://news.medxy.ai/extracranial-bleeding-risk-on-oral-anticoagulants-in-atrial-fibrillation-insights-from-combine-af-analysis/Medxy AIen2026-08-05T12:06:25-07:00Extracranial Bleeding Risk on Oral Anticoagulants in Atrial Fibrillation: Insights from COMBINE-AF Analysis https://news.medxy.ai/zh/breast-reconstruction-type-and-placement-on-radiation-therapy-outcomes/Medxy AIzh2026-08-05T11:59:43-07:00乳房重建方式与放置位置对放射治疗结局的影响：临床观察与启示 https://news.medxy.ai/vi/breast-reconstruction-type-and-placement-on-radiation-therapy-outcomes-clinical-insights-and-implications/Medxy AIvi2026-08-05T11:59:05-07:00Loại tái tạo vú và vị trí đặt thiết bị ảnh hưởng thế nào đến kết quả xạ trị? Góc nhìn lâm sàng và ý nghĩa thực hành https://news.medxy.ai/influence-of-breast-reconstruction-type-and-placement-on-radiation-therapy-outcomes-clinical-insights-and-implications/Medxy AIen2026-08-05T11:58:17-07:00Influence of Breast Reconstruction Type and Placement on Radiation Therapy Outcomes: Clinical Insights and Implications https://news.medxy.ai/zh/time-dependent-symptom-improvement-in-schizophrenia-3/Medxy AIzh2026-08-05T11:57:17-07:00精神分裂症症状改善的时间差异：来自6项抗精神病药物试验的启示 https://news.medxy.ai/ja/time-dependent-symptom-improvement-in-schizophrenia-2/Medxy AIja2026-08-05T11:57:01-07:00統合失調症の症状改善はいつ起こるのか：6件の抗精神病薬試験から見えた時間的変化 https://news.medxy.ai/vi/time-dependent-symptom-improvement-in-schizophrenia/Medxy AIvi2026-08-05T11:56:44-07:00Cải thiện triệu chứng tâm thần phân liệt theo thời gian: Phân tích từ sáu thử nghiệm thuốc chống loạn thần https://news.medxy.ai/time-dependent-symptom-improvement-in-schizophrenia-insights-from-six-antipsychotic-trials/Medxy AIen2026-08-05T11:55:58-07:00Time-Dependent Symptom Improvement in Schizophrenia: Insights from Six Antipsychotic Trials https://news.medxy.ai/zh/renal-resistive-index-to-map-targets-in-early-septic-shock/Medxy AIzh2026-08-05T11:55:39-07:00早期脓毒性休克中肾阻力指数对MAP目标的反应性：临床意义与生理学启示 https://news.medxy.ai/ja/renal-resistive-index-responsiveness-to-map-targets-in-early-septic-shock/Medxy AIja2026-08-05T11:55:20-07:00早期敗血症性ショックにおける腎抵抗指数の反応性とMAP目標の検討：臨床的意義と生理学的考察 https://news.medxy.ai/vi/renal-resistive-index-responsiveness-to-map-targets-in-early-septic-shock-clinical-implications-and-physiologic/Medxy AIvi2026-08-05T11:55:00-07:00Đánh giá đáp ứng của chỉ số kháng trở thận với mục tiêu MAP trong sốc nhiễm khuẩn sớm: ý nghĩa lâm sàng và những hiểu biết sinh lý học https://news.medxy.ai/evaluating-renal-resistive-index-responsiveness-to-map-targets-in-early-septic-shock-clinical-implications-and-physiologic-insights/Medxy AIen2026-08-05T11:54:12-07:00Evaluating Renal Resistive Index Responsiveness to MAP Targets in Early Septic Shock: Clinical Implications and Physiologic Insights https://news.medxy.ai/zh/harnessing-chatgpt-for-pediatric-emergency-care-in-early-medical-history-retrieval-pilot-study/Medxy AIzh2026-08-05T11:51:02-07:00赋能儿科急诊：基于 ChatGPT 的早期病史采集试点研究 https://news.medxy.ai/ja/chatgpt-driven-early-medical-history/Medxy AIja2026-08-05T11:50:44-07:00小児救急におけるAI活用：ChatGPTが導く早期病歴収集のパイロット研究 https://news.medxy.ai/vi/harnessing-ai-for-pediatric-emergency-care-chatgpt-driven-early-medical-history/Medxy AIvi2026-08-05T11:50:23-07:00Ứng dụng AI trong cấp cứu nhi: nghiên cứu thí điểm về khai thác sớm bệnh sử bằng ChatGPT https://news.medxy.ai/harnessing-ai-for-pediatric-emergency-care-chatgpt-driven-early-medical-history-retrieval-pilot-study/Medxy AIen2026-08-05T11:49:36-07:00Harnessing AI for Pediatric Emergency Care: ChatGPT-Driven Early Medical History Retrieval Pilot Study https://news.medxy.ai/zh/medical-education-on-competence-and-patient-outcomes/Medxy AIzh2026-08-05T11:48:42-07:00优化医学教育：结构化患者出院课程对医学生能力与患者结局的影响 https://news.medxy.ai/ja/medical-education-on-student-competence-and-patient-outcomes/Medxy AIja2026-08-05T11:48:28-07:00退院指導教育の効果を検証：構造化カリキュラムが学生の能力と患者アウトカムに与える影響 https://news.medxy.ai/vi/medical-education-impact-of-a-structured-patient-discharge-curriculum-on-student-competence-and-patient-outcomes/Medxy AIvi2026-08-05T11:48:10-07:00Nâng cao giáo dục y khoa: Tác động của chương trình đào tạo có cấu trúc về xuất viện đối với năng lực sinh viên và kết cục người bệnh https://news.medxy.ai/enhancing-medical-education-impact-of-a-structured-patient-discharge-curriculum-on-student-competence-and-patient-outcomes/Medxy AIen2026-08-05T11:47:27-07:00Enhancing Medical Education: Impact of a Structured Patient Discharge Curriculum on Student Competence and Patient Outcomes https://news.medxy.ai/ja/telehealth-community-health-worker-clinician-feedback-and-diabetes-outcomes/Medxy AIja2026-08-05T11:44:02-07:00構造化された遠隔医療フィードバックを用いた地域保健ワーカーと臨床医の連携がもたらす糖尿病転帰：ランダム化臨床試験 https://news.medxy.ai/vi/structured-telehealth-community-health-worker-clinician-feedback-and-diabetes-outcomes/Medxy AIvi2026-08-05T11:43:40-07:00Mô hình phản hồi có cấu trúc giữa nhân viên y tế cộng đồng và bác sĩ qua telehealth cải thiện kết cục đái tháo đường: một thử nghiệm lâm sàng ngẫu nhiên https://news.medxy.ai/structured-telehealth-community-health-worker-clinician-feedback-and-diabetes-outcomes-a-randomized-clinical-trial/Medxy AIen2026-08-05T11:42:50-07:00Structured Telehealth Community Health Worker-Clinician Feedback and Diabetes Outcomes: A Randomized Clinical Trial https://news.medxy.ai/vi/the-risk-of-anterior-ischemic-optic-neuropathy-with-glp-1-receptor-agonists-in-type-2-diabetes/Medxy AIvi2026-08-05T10:35:45-07:00Đánh giá nguy cơ bệnh thần kinh thị giác thiếu máu cục bộ trước khi dùng chất chủ vận thụ thể GLP-1 ở đái tháo đường type 2: Dữ liệu từ một nghiên cứu đoàn hệ toàn quốc tại Thụy Điển https://news.medxy.ai/evaluating-the-risk-of-anterior-ischemic-optic-neuropathy-with-glp-1-receptor-agonists-in-type-2-diabetes-insights-from-a-swedish-nationwide-cohort-study/Medxy AIen2026-08-05T10:34:47-07:00Evaluating the Risk of Anterior Ischemic Optic Neuropathy with GLP-1 Receptor Agonists in Type 2 Diabetes: Insights from a Swedish Nationwide Cohort Study https://news.medxy.ai/zh/outcomes-in-poems-syndrome-real-world-on-autologous-stem-cell-transplantation/Medxy AIzh2026-08-05T10:34:06-07:00POEMS综合征治疗优化：一项多中心研究揭示自体造血干细胞移植的真实世界结局 https://news.medxy.ai/ja/outcomes-in-poems-syndrome-real-world-insights-on-autologous-stem-cell-transplantation/Medxy AIja2026-08-05T10:33:48-07:00POEMS症候群の治療成績を高める鍵：多施設研究が示す自家造血幹細胞移植の実臨床エビデンス https://news.medxy.ai/vi/optimizing-outcomes-in-poems-syndrome-real-world-insights-on-autologous-stem-cell-transplantation/Medxy AIvi2026-08-05T10:33:27-07:00Tối ưu hóa kết cục trong hội chứng POEMS: Góc nhìn thực tế về ghép tế bào gốc tự thân từ một nghiên cứu đa trung tâm https://news.medxy.ai/optimizing-outcomes-in-poems-syndrome-real-world-insights-on-autologous-stem-cell-transplantation-from-a-multicenter-study/Medxy AIen2026-08-05T10:32:31-07:00Optimizing Outcomes in POEMS Syndrome: Real-World Insights on Autologous Stem Cell Transplantation from a Multicenter Study https://news.medxy.ai/zh/anti-pd-1-for-classical-hodgkin-lymphoma-treatment/Medxy AIzh2026-08-05T10:06:01-07:00重塑经典型霍奇金淋巴瘤治疗格局：抗 PD-1 治疗的前景 https://news.medxy.ai/ja/anti-pd-1-therapy-for-classical-hodgkin-lymphoma-treatment/Medxy AIja2026-08-05T10:05:43-07:00古典的ホジキンリンパ腫治療を変える抗PD-1療法：新たな可能性 https://news.medxy.ai/vi/revolutionizing-classical-hodgkin-lymphoma-treatment/Medxy AIvi2026-08-05T10:05:21-07:00Cách mạng hóa điều trị u lympho Hodgkin cổ điển: triển vọng của liệu pháp kháng PD-1 https://news.medxy.ai/revolutionizing-classical-hodgkin-lymphoma-treatment-the-promise-of-anti-pd-1-therapy/Medxy AIen2026-08-05T10:04:07-07:00Revolutionizing Classical Hodgkin Lymphoma Treatment: The Promise of Anti-PD-1 Therapy https://news.medxy.ai/zh/breast-implant-link-anaplastic-large-cell-lymphoma/Medxy AIzh2026-08-05T10:02:37-07:00乳房植入物相关间变性大细胞淋巴瘤：细胞异质性、免疫抑制及治疗新机遇 https://news.medxy.ai/ja/breast-implant-associated-anaplastic-large-cell-lymphoma/Medxy AIja2026-08-05T10:02:16-07:00乳房インプラント関連未分化大細胞リンパ腫：細胞多様性、免疫抑制、治療機会を探る https://news.medxy.ai/vi/breast-implant-associated-anaplastic-large-cell-lymphoma-insights-into-cellular-diversity-immune-suppression-and-therapeutic-opportunities-2/Medxy AIvi2026-08-05T10:01:48-07:00U lympho tế bào lớn anaplastic liên quan đến túi độn ngực: Khám phá tính không đồng nhất tế bào, ức chế miễn dịch và các cơ hội điều trị https://news.medxy.ai/breast-implant-associated-anaplastic-large-cell-lymphoma-insights-into-cellular-diversity-immune-suppression-and-therapeutic-opportunities/Medxy AIen2026-08-05T10:00:11-07:00Breast Implant-Associated Anaplastic Large Cell Lymphoma: Insights into Cellular Diversity, Immune Suppression, and Therapeutic Opportunities https://news.medxy.ai/unexpected-prognostic-significance-of-flt3-itd-microclones-in-young-adults-with-acute-myeloid-leukemia-undergoing-intensive-chemotherapy/Medxy AIen2026-08-05T09:51:40-07:00Unexpected Prognostic Significance of FLT3-ITD Microclones in Young Adults with Acute Myeloid Leukemia Undergoing Intensive Chemotherapy